915404

CorePharma, LLC — FEI 3002535019

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Middlesex, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)